Trade China Life Insurance Company Limited - 2628 CFD

Trading Conditions
Spread0.35
Long position overnight fee
Long position overnight fee

Margin. Your investment
HK$1,000.00
Overnight fee
Charges from full value of position
-0.021963 %
(-HK$0.88)

Trade size with leverage ~ HK$5,000.00

Short position overnight fee ~ HK$4,000.00


-0.021963%
Short position overnight fee
Short position overnight fee

Margin. Your investment
HK$1,000.00
Overnight fee
Charges from full value of position
0.000045 %
(HK$0.00)

Trade size with leverage ~ HK$5,000.00

Short position overnight fee ~ HK$4,000.00


0.000045%
Overnight fee time21:00 (UTC)
CurrencyHKD
Min traded quantity1
Margin20
Stock exchangeHong Kong
Commission on trade10%

Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close9.95
Open10.05
1-Year Change-28.47%
Day's Range9.9 - 10.15

China Life Company profile

About China Life Insurance Co Ltd

China Life Insurance Company Limited is a life insurance company. The Company provides a range of insurance products, including individual and group life insurance, health insurance and accident insurance products. It operates through three segments: Life Insurance, Health Insurance, and Accident Insurance. Its Life Insurance segment provides participating and non-participating life insurance and annuities to individuals and groups. Its Health Insurance segment provides short-term and long-term health insurance to individuals and groups. Its Accident Insurance segment provides short-term and long-term accident insurance to individuals and groups.

Financial summary

BRIEF: For the six months ended 30 June 2021, China Life Insurance Co Ltd revenues increased 7% to RMB544.71B. Net income increased 34% to RMB40.98B. Revenues reflect Life segment increase of 6% to RMB454.88B, Health segment increase of 8% to RMB64.69B. Net income benefited from Underwriting and policy acquisition cost decrease of 25% to RMB42.11B (expense), Net gains on investments of associates a increase of 91% to RMB7.68B (income).